166 related articles for article (PubMed ID: 7928239)
1. Magnetic resonance lymphography. Enhancement patterns using superparamagnetic nanoparticles.
Clément O; Guimaraes R; de Kerviler E; Frija G
Invest Radiol; 1994 Jun; 29 Suppl 2():S226-8. PubMed ID: 7928239
[No Abstract] [Full Text] [Related]
2. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.
Guimaraes R; Clément O; Bittoun J; Carnot F; Frija G
AJR Am J Roentgenol; 1994 Jan; 162(1):201-7. PubMed ID: 8273666
[TBL] [Abstract][Full Text] [Related]
3. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic nanoparticles as blood-pool contrast agents. Contribution to MRI preclinical investigations.
Benderbous S; Bonnemain B
Radiologe; 1995 Nov; 35(11 Suppl 2):S248-52. PubMed ID: 8588030
[No Abstract] [Full Text] [Related]
5. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Montie JE
J Urol; 2005 Sep; 174(3):870-1. PubMed ID: 16093977
[No Abstract] [Full Text] [Related]
6. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients.
Barentsz JO; Fütterer JJ; Takahashi S
Eur J Radiol; 2007 Sep; 63(3):369-72. PubMed ID: 17689215
[TBL] [Abstract][Full Text] [Related]
7. MR lymphography: evidence of extravasation of superparamagnetic nanoparticles into the lymph.
Clement O; Rety F; Cuenod CA; Siauve N; Carnot F; Bordat C; Siche M; Frija G
Acad Radiol; 1998 Apr; 5 Suppl 1():S170-2; discussion S183-4. PubMed ID: 9561073
[No Abstract] [Full Text] [Related]
8. [Identification of sentinel lymph nodes and mapping procedure of sentinel lymph nodes for breast cancer].
Nohara T; Harada T; Tanigawa N
Nihon Rinsho; 2007 Jun; 65 Suppl 6():193-7. PubMed ID: 17682156
[No Abstract] [Full Text] [Related]
9. [Sentinel lymph node after intramammary injection of superparamagnetic iron oxide].
Ishiyama K; Sashi R; Katayose Y; Tomura N; Watarai J; Narita K
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Nov; 62(13):744-6. PubMed ID: 12508494
[TBL] [Abstract][Full Text] [Related]
10. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes.
Vassallo P; Matei C; Heston WD; McLachlan SJ; Koutcher JA; Castellino RA
Radiology; 1994 Nov; 193(2):501-6. PubMed ID: 7972768
[TBL] [Abstract][Full Text] [Related]
11. Experimental investigation of the delivery pathway of ultrasmall superparamagnetic iron oxide to lymph nodes.
Frija G; Clément O; Le Guen O; Cuénod CA; Siauve N; Benderbous S
Acad Radiol; 1996 Aug; 3 Suppl 2():S299-300. PubMed ID: 8796586
[No Abstract] [Full Text] [Related]
12. MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex).
Harisinghani MG; Saini S; Hahn PF; Weissleder R; Mueller PR
Acad Radiol; 1998 Apr; 5 Suppl 1():S167-9, discussion S183-4. PubMed ID: 9561072
[No Abstract] [Full Text] [Related]
13. Magnetic resonance lymphography: a novel technique for lymph node assessment in gynecologic malignancies.
Narayanan P; Iyngkaran T; Sohaib SA; Reznek RH; Rockall AG
Cancer Biomark; 2009; 5(2):81-8. PubMed ID: 19414925
[TBL] [Abstract][Full Text] [Related]
14. Pearls and pitfalls of MR lymphography in gynecologic malignancy.
Narayanan P; Iyngkaran T; Sohaib SA; Reznek RH; Rockall AG
Radiographics; 2009; 29(4):1057-69; discussion 1069-71. PubMed ID: 19605656
[TBL] [Abstract][Full Text] [Related]
15. [Use of ultrasmall ferric oxide (Sinerem) particles as a magnetic resonance contrast substance for imaging lymph nodal metastases in cancer of the head and neck].
Sviridov NK; Napolov IuK; Bolotova EN; Iakobs LV
Vestn Rentgenol Radiol; 2004; (3):63-4. PubMed ID: 15587888
[No Abstract] [Full Text] [Related]
16. Use of USPIO-induced magnetic susceptibility artifacts to identify sentinel lymph nodes and lymphatic drainage patterns. I. Dependence of artifact size with subcutaneous Combidex dose in rats.
Rogers JM; Jung CW; Lewis J; Groman EV
Magn Reson Imaging; 1998 Oct; 16(8):917-23. PubMed ID: 9814774
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography.
Bellin MF; Lebleu L; Meric JB
Abdom Imaging; 2003; 28(2):155-63. PubMed ID: 12592461
[TBL] [Abstract][Full Text] [Related]
18. Visualization of lymphatic basin from the tumor using magnetic resonance lymphography with superparamagnetic iron oxide in patients with thoracic esophageal cancer.
Ishiyama K; Motoyama S; Tomura N; Sashi R; Imano H; Ogawa J; Narita K; Watarai J
J Comput Assist Tomogr; 2006; 30(2):270-5. PubMed ID: 16628046
[TBL] [Abstract][Full Text] [Related]
19. Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.
Ross RW; Zietman AL; Xie W; Coen JJ; Dahl DM; Shipley WU; Kaufman DS; Islam T; Guimaraes AR; Weissleder R; Harisinghani M
Clin Imaging; 2009; 33(4):301-5. PubMed ID: 19559353
[TBL] [Abstract][Full Text] [Related]
20. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
Saksena MA; Saokar A; Harisinghani MG
Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
